Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.579 USD | +10.50% | +1.33% | -45.90% |
03-21 | Transcript : Ensysce Biosciences, Inc., Q4 2023 Earnings Call, Mar 21, 2024 | |
03-15 | Ensysce Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.90% | 3.97M | |
+24.00% | 44.96B | |
+0.38% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+10.58% | 26.08B | |
-21.16% | 19.03B | |
+6.75% | 12.75B | |
+28.83% | 12.06B | |
-3.46% | 11.75B |
- Stock Market
- Equities
- ENSC Stock
- News Ensysce Biosciences, Inc.
- Lake Street Adjusts Price Target on Ensysce Biosciences to $8 From $80, Maintains Buy Rating